Another study followed fifteen patients with three different AIDs including SLE, idiopathic inflammatory myositis, and systemic sclerosis for two years; they were treated with a single infusion of T cells with CD19-chimeric antigen receptor (51). Here, CD19 is linked to systemic lupus erythematosus.